首頁 > 市場調查報告書 > 醫療設備

體外診斷

2030 年亞太地區凝血市場預測 - 區域分析 - 按疾病適應症、類型、產品、技術和最終用戶

市場調查報告書

商品編碼

1494294

2030 年亞太地區凝血市場預測 - 區域分析 - 按疾病適應症、類型、產品、技術和最終用戶

Asia Pacific Coagulation Market Forecast to 2030 - Regional Analysis - by Disease Indications, Type, Offering, Technology, and End User

出版日期: 2024年03月14日 | 出版商:

The Insight Partners | 英文 113 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年亞太地區凝血市場估值為8.8952億美元，預計2030年將達16.7249億美元；預計2022年至2030年複合年成長率為8.2%。

主要市場參與者不斷發展的有機和無機策略推動亞太混凝市場

生活習慣的改變和老年人口的增加是增加血液疾病盛行率的主要因素。因此，早期診斷和治療的需求日益成長。主要參與者正在透過各種有機和無機策略採取多項舉措，以提高患者群體的生活品質。

2020年7月，希森美康公司在日本推出自動凝血分析儀CN-6500/CN-3500。此分析儀可測量凝血和血小板聚集參數，以及血栓形成和止血參數。
2021 年 10 月，Trivitron Healthcare 推出了由印度 Diagon Ltd 製造的新系列凝血分析儀產品。
2021 年 6 月，Trivitron Healthcare 推出了 NANO H5 和 NANO H110，有助於監測糖尿病、血紅素變異和地中海貧血。
2021 年 2 月，西門子醫療與希森美康公司續簽了全球供應、分銷、銷售和服務止血產品的協議。該協議還包括延期多年。此外，西門子 Healthineers 也同意分銷 Sysmex 的自動凝血分析儀，例如 CN-3000 和 CN-6000。
2022年7月，HORIBA Medical推出了最新的Yumizen G800和G1550止血分析儀，以及一系列用於常見凝血的便捷即用型試劑產品。隨著產品線的擴展，HORIBA Medical 現在為各種規模和要求的實驗室提供全面的止血系統和先進試劑選擇。

因此，主要市場參與者採用各種有機和無機策略預計將為預測期內混凝市場的成長提供機會。

亞太地區凝血市場概況

亞太地區凝血市場分為中國、日本、印度、韓國、澳洲和亞太其他地區。促進該地區市場進步的因素包括老年人口的增加、心血管疾病發病率的增加、出血性疾病盛行率的增加、分銷網路的發展以及凝血分析儀的進步。

根據國家生物技術資訊中心（NCBI）發表的《2022年中國心血管健康與疾病》文章，心血管疾病（CVD）分別佔農村和城市地區約47%和約44%的死亡原因分別在中國。 2020年，預計中國將有近3.3億患者患有心血管疾病。根據《柳葉刀》發表的一項研究，心血管疾病每年在中國導致約 400 萬人死亡。 CVD患者體內的凝血因子濃度升高。因此，心血管疾病盛行率的激增正在推動中國凝血市場的成長。

亞太地區凝血市場收入及 2030 年預測（百萬美元）

亞太地區凝血市場細分

亞太地區凝血市場根據疾病適應症、類型、產品、技術、最終用戶和國家進行細分。

根據疾病適應症，亞太地區凝血市場分為維生素 K 缺乏症、肝病、瀰漫性血管內凝血及肺栓塞、循環抗凝血劑的發展、血友病、馮維勒布蘭德氏症等。 2022 年，肝病領域佔據亞太地區最大的凝血市場。

根據類型，亞太凝血市場分為臨床實驗室分析儀和即時檢測分析儀。 2022 年，臨床實驗室分析儀細分市場將在亞太地區凝血市場中佔據更大佔有率。凝血因子等。

在產品方面，亞太地區凝血市場分為診斷和治療。至2022年，診斷細分市場將佔據更大的亞太凝血市場佔有率。 D-二聚體測試、血小板功能測試等。治療部分進一步細分為抗纖溶藥物、避孕藥、去氨加壓素和免疫抑制藥物、維生素K 補充劑、血液稀釋劑、凝血酶抑制劑或血栓溶解劑、替代療法、導管輔助血栓清除等。

依技術分類，亞太凝固市場分為光學技術、機械技術、電化學技術等。 2022 年，光學技術領域佔據亞太地區最大的凝血市場。

依最終用戶分類，亞太地區凝血市場分為臨床實驗室、醫院等。 2022 年，醫院細分市場佔據亞太地區最大的凝血市場。

依國家分類，亞太地區凝血市場分為中國、日本、印度、韓國、澳洲和亞太其他地區。 2022年，中國在亞太地區凝血市場佔據主導地位。

F.霍夫曼-拉羅氏有限公司；根瑞生物科技有限公司；堀場有限公司； ImproGen Diagnostik Kimya San & Tic Ltd.Sti.、Siemens Healthineers AG；希森美康公司；和 Transasia Bio-Medicals Ltd 是亞太凝血市場上的一些領先公司。

Changing lifestyle habits and a growing geriatric population are among the major factors increasing the prevalence of blood disorders. Therefore, there is a growing demand for early diagnosis and treatment. Key players are taking several initiatives through various organic and inorganic strategies to enhance the quality of life of patient population.

In July 2020, Sysmex Corporation launched the Automated Blood Coagulation Analyzers CN-6500/CN-3500 in Japan. The analyzer measures blood coagulation and platelet aggregation parameters, as well as thrombosis and hemostasis parameters.
In October 2021, Trivitron Healthcare launched a new line of coagulation analyzer products manufactured by Diagon Ltd in India.
In June 2021, Trivitron Healthcare introduced NANO H5 and NANO H110, which help in monitoring diabetes, hemoglobin variations, and thalassemia.
In February 2021, Siemens Healthineers and Sysmex Corporation renewed their agreement to supply, distribute, sell, and service hemostasis products across the world. The agreement also included an extension for multiple years. Further, Siemens Healthineers agreed to distribute Sysmex's automated blood coagulation analyzer, such as the CN-3000 and CN-6000.
In July 2022, HORIBA Medical launched the latest Yumizen G800 and G1550 hemostasis analyzers, as well as a range of convenient ready-to-use reagents for common blood coagulation Offerings. With this expansion of its product line, HORIBA Medical now offers a comprehensive selection of hemostasis systems and advanced reagents for laboratories of all sizes and requirements.

Thus, the adoption of various organic and inorganic strategies by the key market players is expected to provide opportunities for the coagulation market growth during the forecast period.

Asia Pacific Coagulation Market Overview

The Asia Pacific coagulation market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The factors contributing to the market progress in this region include the rising geriatric population, increasing incidences of cardiovascular diseases, growing prevalence of bleeding disorders, development of distribution networks, and advancements in coagulation analyzers.

According to an article published in the National Center for Biotechnology Information (NCBI), "Cardiovascular Health and Diseases in China 2022," cardiovascular diseases (CVD) are the cause of ~47% and ~44% of all deaths in rural and urban regions in China, respectively. In 2020, nearly 330 million patients are predicted to suffer from CVD in China. According to a research study published in The Lancet, CVDs cause ~4 million deaths each year in China. CVD patients have elevated levels of coagulation factors in their bodies. Hence, an upsurge in the prevalence of CVDs is fueling the growth of the coagulation market in China.

Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Coagulation Market Segmentation

The Asia Pacific coagulation market is segmented based on disease indication, type, offering, technology, end user, and country.

Based on disease indication, the Asia Pacific coagulation market is segmented into vitamin k deficiency, liver disease, disseminated intravascular coagulation and pulmonary embolism, development of circulating anticoagulants, hemophilia, von willebrand's disease, and others. The liver disease segment held the largest Asia Pacific coagulation market share in 2022.

Based on type, the Asia Pacific coagulation market is bifurcated into clinical laboratory analysers and point-of-care testing analyzers. The clinical laboratory analysers segment held a larger Asia Pacific coagulation market share in 2022. Clinical laboratory analysers segment is further subsegmented into controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others.

In terms of offering, the Asia Pacific coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held a larger Asia Pacific coagulation market share in 2022. Diagnosis segment is further subsegmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimmer testing, platelets function testing, and others. Treatment segment is further subsegmented into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin k supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapy, catheter-assisted thrombus removal, and others.

By technology, the Asia Pacific coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment held the largest Asia Pacific coagulation market share in 2022.

By end user, the Asia Pacific coagulation market is segmented into clinical laboratories, hospitals, and others. The hospitals segment held the largest Asia Pacific coagulation market share in 2022.

Based on country, the Asia Pacific coagulation market is categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific coagulation market in 2022.

F. Hoffmann-La Roche Ltd; Genrui Biotech Co., Ltd.; Horiba Ltd; ImproGen Diagnostik Kimya San & Tic Ltd.Sti., Siemens Healthineers AG; Sysmex Corp; and Transasia Bio-Medicals Ltd are some of the leading companies operating in the Asia Pacific coagulation market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Coagulation Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of Blood Disorders
- 4.1.2 Rising Prevalence of Cardiovascular Diseases
4.2 Market Restraints
- 4.2.1 High Costs Associated with Coagulation Analyzers
4.3 Market Opportunities
- 4.3.1 Growing Organic and Inorganic Strategies by Key Market Players
4.4 Future Trends
- 4.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
4.5 Impact Analysis

5. Coagulation Market - Asia Pacific Market Analysis

5.1 Asia Pacific Coagulation Market Revenue (US$ million), 2022 - 2030

6. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication

6.1 Overview
6.2 Asia Pacific Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
6.3 Vitamin K Deficiency
- 6.3.1 Overview
- 6.3.2 Vitamin K Deficiency: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Liver Disease
- 6.4.1 Overview
- 6.4.2 Liver Disease: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
- 6.5.1 Overview
- 6.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Development of Circulating Anticoagulant
- 6.6.1 Overview
- 6.6.2 Development of Circulating Anticoagulant: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Hemophilia
- 6.7.1 Overview
- 6.7.2 Hemophilia: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.8 Von Willebrand's Disease
- 6.8.1 Overview
- 6.8.2 Von Willebrand's Disease: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.9 Others
- 6.9.1 Overview
- 6.9.2 Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by Type

7.1 Overview
7.2 Asia Pacific Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Clinical Laboratory Analyzers
- 7.3.1 Overview
- 7.3.2 Clinical Laboratory Analyzers: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 Asia Pacific Coagulation Market, by Clinical Laboratory Analyzers
7.4 Point-of-Care Testing Analyzers
- 7.4.1 Overview
- 7.4.2 Point-of-Care Testing Analyzers: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by Offering

8.1 Overview
8.2 Asia Pacific Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
8.3 Diagnosis
- 8.3.1 Overview
- 8.3.2 Diagnosis: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 Asia Pacific Coagulation Market, by Diagnosis
8.4 Treatment
- 8.4.1 Overview
- 8.4.2 Treatment: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.4.2.1 Asia Pacific Coagulation Market, by Treatment

9. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by Technology

9.1 Overview
9.2 Asia Pacific Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
9.3 Optical Technology
- 9.3.1 Overview
- 9.3.2 Optical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Mechanical Technology
- 9.4.1 Overview
- 9.4.2 Mechanical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Electrochemical Technology
- 9.5.1 Overview
- 9.5.2 Electrochemical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 Asia Pacific Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Clinical Laboratories
- 10.3.1 Overview
- 10.3.2 Clinical Laboratories: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Hospitals
- 10.4.1 Overview
- 10.4.2 Hospitals: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Coagulation Market - Country Analysis

11.1 Asia Pacific Coagulation Market, Revenue and Forecast to 2030
- 11.1.1 Asia Pacific Coagulation Market by Country
  - 11.1.1.1 China
    - 11.1.1.1.1 China Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.1.2 China Coagulation Market, by Disease Indication
    - 11.1.1.1.3 China Coagulation Market, by Type
    - 11.1.1.1.3.1 China Coagulation Market, by Clinical Laboratory Analyzer
    - 11.1.1.1.4 China Coagulation Market, by Offering
    - 11.1.1.1.4.1 China Coagulation Market, by Diagnosis
    - 11.1.1.1.4.2 China Coagulation Market, by Treatment
    - 11.1.1.1.5 China Coagulation Market, by Technology
    - 11.1.1.1.6 China Coagulation Market, by End User
  - 11.1.1.2 Japan
    - 11.1.1.2.1 Overview
    - 11.1.1.2.2 Japan Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.2.3 Japan Coagulation Market, by Disease Indication
    - 11.1.1.2.4 Japan Coagulation Market, by Type
    - 11.1.1.2.4.1 Japan Coagulation Market, by Clinical Laboratory Analyzer
    - 11.1.1.2.5 Japan Coagulation Market, by Offering
    - 11.1.1.2.5.1 Japan Coagulation Market, by Diagnosis
    - 11.1.1.2.5.2 Japan Coagulation Market, by Treatment
    - 11.1.1.2.6 Japan Coagulation Market, by Technology
    - 11.1.1.2.7 Japan Coagulation Market, by End User
  - 11.1.1.3 India
    - 11.1.1.3.1 Overview
    - 11.1.1.3.2 India Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.3.3 India Coagulation Market, by Disease Indication
    - 11.1.1.3.4 India Coagulation Market, by Type
    - 11.1.1.3.4.1 India Coagulation Market, by Clinical Laboratory Analyzer
    - 11.1.1.3.5 India Coagulation Market, by Offering
    - 11.1.1.3.5.1 India Coagulation Market, by Diagnosis
    - 11.1.1.3.5.2 India Coagulation Market, by Treatment
    - 11.1.1.3.6 India Coagulation Market, by Technology
    - 11.1.1.3.7 India Coagulation Market, by End User
  - 11.1.1.4 Australia
    - 11.1.1.4.1 Overview
    - 11.1.1.4.2 Australia Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.4.3 Australia Coagulation Market, by Disease Indication
    - 11.1.1.4.4 Australia Coagulation Market, by Type
    - 11.1.1.4.4.1 Australia Coagulation Market, by Clinical Laboratory Analyzer
    - 11.1.1.4.5 Australia Coagulation Market, by Offering
    - 11.1.1.4.5.1 Australia Coagulation Market, by Diagnosis
    - 11.1.1.4.5.2 Australia Coagulation Market, by Treatment
    - 11.1.1.4.6 Australia Coagulation Market, by Technology
    - 11.1.1.4.7 Australia Coagulation Market, by End User
  - 11.1.1.5 South Korea
    - 11.1.1.5.1 Overview
    - 11.1.1.5.2 South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.5.3 South Korea Coagulation Market, by Disease Indication
    - 11.1.1.5.4 South Korea Coagulation Market, by Type
    - 11.1.1.5.4.1 South Korea Coagulation Market, by Clinical Laboratory Analyzer
    - 11.1.1.5.5 South Korea Coagulation Market, by Offering
    - 11.1.1.5.5.1 South Korea Coagulation Market, by Diagnosis
    - 11.1.1.5.5.2 South Korea Coagulation Market, by Treatment
    - 11.1.1.5.6 South Korea Coagulation Market, by Technology
    - 11.1.1.5.7 South Korea Coagulation Market, by End User
  - 11.1.1.6 Rest of Asia Pacific
    - 11.1.1.6.1 Overview
    - 11.1.1.6.2 Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.6.3 Rest of Asia Pacific Coagulation Market, by Disease Indication
    - 11.1.1.6.4 Rest of Asia Pacific Coagulation Market, by Type
    - 11.1.1.6.4.1 Rest of Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer
    - 11.1.1.6.5 Rest of Asia Pacific Coagulation Market, by Offering
    - 11.1.1.6.5.1 Rest of Asia Pacific Coagulation Market, by Diagnosis
    - 11.1.1.6.5.2 Rest of Asia Pacific Coagulation Market, by Treatment
    - 11.1.1.6.6 Rest of Asia Pacific Coagulation Market, by Technology
    - 11.1.1.6.7 Rest of Asia Pacific Coagulation Market, by End User

12. Coagulation Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Coagulation Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 Siemens Healthineers AG
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Sysmex Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Genrui Biotech Co., Ltd.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Transasia Bio-Medicals Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Horiba Ltd.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Asia Pacific Coagulation Market Segmentation
Table 2. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 3. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 4. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 5. Optical Technologies and Their Applications
Table 6. Mechanical Technologies and Their Applications
Table 7. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 8. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 9. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 10. China Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 11. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 12. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 13. China Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 14. China Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 15. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 16. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 17. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 18. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 19. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 20. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 21. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 22. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 23. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 24. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 25. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 26. India Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 27. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 28. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 29. India Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 30. India Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 31. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 32. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 33. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 34. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 35. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 36. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 37. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 38. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 39. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 40. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 41. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 42. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 43. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 44. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 45. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 46. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 47. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 48. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 49. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 50. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 51. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 52. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 53. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 54. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 55. Recent Inorganic Growth Strategies in the Coagulation Market
Table 56. Recent Organic Growth Strategies in the Coagulation Market
Table 57. Glossary of Terms, Coagulation Market

List Of Figures

Figure 1. Asia Pacific Coagulation Market Segmentation, By Country
Figure 2. Asia Pacific Coagulation Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Coagulation Market Revenue (US$ million), 2020 - 2030
Figure 5. Asia Pacific Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
Figure 6. Vitamin K Deficiency: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Liver Disease: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Disseminated Intravascular Coagulation and Pulmonary Embolism: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Development of Circulating Anticoagulant: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Hemophilia: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Von Willebrand's Disease: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Asia Pacific Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
Figure 14. Clinical Laboratory Analyzers: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Point-of-Care Testing Analyzers: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Asia Pacific Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
Figure 17. Diagnosis: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Treatment: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Asia Pacific Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 20. Optical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Mechanical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Electrochemical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Asia Pacific Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
Figure 25. Clinical Laboratories: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Hospitals: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Coagulation Market, By Geography, 2022 (US$ Million)
Figure 29. Asia Pacific Coagulation Market, By Key Countries, 2022 and 2030 (%)
Figure 30. China Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 31. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 32. India Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 33. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 34. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 35. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 36. Growth Strategies in the Coagulation Market